Zimmer Biomet Holdings, Inc. (FRA:ZIM)

Market Cap	14.53B -29.5%
Revenue (ttm)	6.83B +5.5%
Net Income	686.36M -25.7%
EPS	3.44 -23.3%
Shares Out	n/a
PE Ratio	21.16
Forward PE	10.39
Dividend	0.84 (1.17%)
Ex-Dividend Date	Dec 30, 2025

Volume	5
Average Volume	11
Open	71.18
Previous Close	71.54
Day's Range	71.18 - 71.46
52-Week Range	71.36 - 107.45
Beta	n/a
RSI	31.71
Earnings Date	Feb 10, 2026

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ZIM

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD